Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Tyler Evangelous"'
Autor:
Bhavna Hora, Hui Li, Xiaoying Shen, Mitchell Martin, Yue Chen, Madison Berry, Tyler Evangelous, Andrew N. Macintyre, Aria Arus-Altuz, Shuyi Wang, Ajay Singh, Chengyan Zhao, Nicole De Naeyer, Todd DeMarco, Cindy Kuykendall, Thaddeus Gurley, Kevin O. Saunders, Thomas Denny, M. Anthony Moody, John Misamore, Mark G. Lewis, Kevin Wiehe, Derek W. Cain, David C. Montefiori, George M. Shaw, Wilton B. Williams
Publikováno v:
Cell Reports, Vol 42, Iss 3, Pp 112255- (2023)
Summary: Infants and children infected with human immunodeficiency virus (HIV)-1 have been shown to develop neutralizing antibodies (nAbs) against heterologous HIV-1 strains, characteristic of broadly nAbs (bnAbs). Thus, having a neonatal model for t
Externí odkaz:
https://doaj.org/article/7dce7418af584710aa80977788fdbcd6
Autor:
Andrew N. Macintyre, PhD, Matthew J. French, BS, Brittany R. Sanders, MS, Kristina J. Riebe, BSA, Ivo D. Shterev, PhD, Kevin Wiehe, PhD, Bhavna Hora, PhD, Tyler Evangelous, BS, Greg Dugan, DVM, J. Daniel Bourland, PhD, J. Mark Cline, DVM, PhD, DACVP, Gregory D. Sempowski, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 6, Iss 5, Pp 100677- (2021)
Purpose: Ionizing radiation causes acute damage to hematopoietic and immune cells, but the long-term immunologic consequences of irradiation are poorly understood. We therefore performed a prospective study of the delayed immune effects of radiation
Externí odkaz:
https://doaj.org/article/cf7a2c6396ce41df9f74b983fd76248e
Autor:
Kevin Wiehe, Kevin O. Saunders, Victoria Stalls, Derek W. Cain, Sravani Venkatayogi, Joshua S. Martin Beem, Madison Berry, Tyler Evangelous, Rory Henderson, Bhavna Hora, Shi-Mao Xia, Chuancang Jiang, Amanda Newman, Cindy Bowman, Xiaozhi Lu, Mary E. Bryan, Joena Bal, Aja Sanzone, Haiyan Chen, Amanda Eaton, Mark A. Tomai, Christopher B. Fox, Ying Tam, Christopher Barbosa, Mattia Bonsignori, Hiromi Muramatsu, S. Munir Alam, David Montefiori, Wilton B. Williams, Norbert Pardi, Ming Tian, Drew Weissman, Frederick W. Alt, Priyamvada Acharya, Barton F. Haynes
A major goal of HIV-1 vaccine development is induction of broadly neutralizing antibodies (bnAbs). While success has been achieved in initiating bnAb B cell lineages, design of boosting immunogens that select for bnAb B cell receptors with improbable
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8ec35f9fb922ae004a0cb0bdff7183c8
https://doi.org/10.1101/2022.11.11.516143
https://doi.org/10.1101/2022.11.11.516143
Autor:
Christopher Barbosa, Amanda Newman, Sravani Venkatayogi, Shi-Mao Xia, Rory Henderson, Wilton B. Williams, Qifeng Han, Barton F. Haynes, Robert J. Edwards, Robert Parks, Kevin O. Saunders, Kevin Wiehe, Mattia Bonsignori, Katayoun Mansouri, Norbert Pardi, Xiaozhi Lu, David C. Montefiori, Tyler Evangelous, Zekun Mu, Wes Rountree, Diana Martik, Yunfei Wang, Drew Weissman, Derek W. Cain, Ying Tam, S. Munir Alam
Publikováno v:
bioRxiv
article-version (status) pre
article-version (number) 1
article-version (status) pre
article-version (number) 1
SUMMARYThe success of nucleoside-modified mRNAs in lipid nanoparticles (mRNA-LNP) as COVID-19 vaccines heralded a new era of vaccine development. For HIV-1, multivalent envelope (Env) trimer protein nanoparticles are superior immunogens compared to t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0e41b1f59f8d8926f0862f1c8d12ac5
https://doi.org/10.1101/2021.08.09.455714
https://doi.org/10.1101/2021.08.09.455714
Autor:
Zekun Mu, Kevin Wiehe, Kevin O. Saunders, Rory Henderson, Derek W. Cain, Robert Parks, Diana Martik, Katayoun Mansouri, Robert J. Edwards, Amanda Newman, Xiaozhi Lu, Shi-Mao Xia, Amanda Eaton, Mattia Bonsignori, David Montefiori, Qifeng Han, Sravani Venkatayogi, Tyler Evangelous, Yunfei Wang, Wes Rountree, Bette Korber, Kshitij Wagh, Ying Tam, Christopher Barbosa, S. Munir Alam, Wilton B. Williams, Ming Tian, Frederick W. Alt, Norbert Pardi, Drew Weissman, Barton F. Haynes
Publikováno v:
Cell reports. 38(11)
The success of nucleoside-modified mRNAs in lipid nanoparticles (mRNA-LNP) as COVID-19 vaccines heralded a new era of vaccine development. For HIV-1, multivalent envelope (Env) trimer protein nanoparticles are superior immunogens compared with trimer
Autor:
Matthew J. French, Andrew N. Macintyre, Bhavna Hora, Greg Dugan, Ivo D. Shterev, J. Daniel Bourland, Tyler Evangelous, J. Mark Cline, Kristina J. Riebe, Brittany Sanders, Gregory D. Sempowski, Kevin Wiehe
Publikováno v:
Advances in Radiation Oncology
Advances in Radiation Oncology, Vol 6, Iss 5, Pp 100677-(2021)
Advances in Radiation Oncology, Vol 6, Iss 5, Pp 100677-(2021)
Purpose Ionizing radiation causes acute damage to hematopoietic and immune cells, but the long-term immunologic consequences of irradiation are poorly understood. We therefore performed a prospective study of the delayed immune effects of radiation u
Autor:
Katarzyna Janowska, Guillaume Stewart-Jones, Ye Zhou, Bhavna Hora, Naomi Bronkema, Tyler Evangelous, Alberto Bartesaghi, John R. Perfect, Hui Li, Robert A. Seder, Michael S. Seaman, Celia C. LaBranche, A. Yousef Abuahmad, Jordan Sprenz, Joseph R. Francica, M. Anthony Moody, Baptiste Aussedat, S. Munir Alam, Garnett Kelsoe, Sampa Santra, Barton F. Haynes, Richard Laga, Priyamvada Acharya, Katayoun Mansouri, Daniela Fera, Victoria Stalls, Nathan I. Nicely, Margaret Deyton, Allen L. Hsu, Madison Berry, George M. Shaw, Megan Kopp, William E. Walkowicz, David C. Montefiori, Gregory D. Sempowski, Matthew S. Lee, Sophie M. C. Gobeil, Mario J. Borgnia, Todd Bradley, Thomas H. Oguin, R. Ryan Meyerhoff, Robert Parks, Kevin Wiehe, Mattia Bonsignori, Peter D. Kwong, Kartik Manne, Geoffrey M. Lynn, Rory Henderson, Robert J. Edwards, Wilton B. Williams, Andrew Foulger, Kevin O. Saunders
Publikováno v:
Cell
Natural antibodies (Abs) can target host glycans on the surface of pathogens. We studied the evolution of glycan-reactive B cells of rhesus macaques and humans using glycosylated HIV-1 envelope (Env) as a model antigen. 2G12 is a broadly neutralizing
Autor:
Eric S. Lipp, Vidyalakshmi Chandramohan, David M. Ashley, Tyler Evangelous, Bhavna Hora, Roger E. McLendon, Darell D. Bigner
Publikováno v:
Neuro-Oncology
BACKGROUND Pediatric glioblastoma (pGBM), despite being relatively rare (incidence rate: 0.5/100,000), are a leading cause of cancer deaths in children with a median overall survival of 9–15 months. In recent years, immunotherapy has emerged as one